Purpose: To identify the prevalence of potential drug-drug interactions (pDDIs) in a psychiatric ward, their levels and association with risk factors. Methods: This study was conducted in the psychiatric ward of Ayub Teaching Hospital, Abbottabad, Pakistan. Medical records of 415 patients were retrospectively reviewed for pDDIs using Micromedex Drug-Reax software. Logistic regression was applied to determine association of pDDIs with age, gender, hospital stay and number of drugs. Results: In our study, we identified total number of 825 pDDIs of 126 types, with median number of 1 pDDIs per patient. Overall 64.8 % of the patients had at least one pDDI; 27.2 % at least one major pDDI; and 58.5 % patients at least one moderate pDDI. Among 825 ...
OBJECTIVE: The objective of this study was to identify Drug-Drug Interaction among the inpatient adm...
Potential drug-drug interactions (pDDIs) are a serious and frequent health issue, leading to often p...
Background: Drug interactions are estimated to occur between 3% and 5% in patients to whom few drugs...
Purpose: To identify the prevalence of potential drug-drug interactions (pDDIs) in a psychiatric war...
Purpose: To identify the prevalence of potential drug-drug interactions (pDDIs) in a psychiatric war...
Purpose: To identify and report the prevalence of potential drug-drug interactions (pDDIs) in a neur...
Purpose: To identify the frequency, levels and predictors of potential drug-drug interactions (pDDIs...
Purpose: To identify the frequency, levels and predictors of potential drug-drug interactions (pDDIs...
Background: Drug-drug interactions (DDIs) contribute majorly to hospital admissions, treatment failu...
Aim and objective: Drug-drug interaction (DDI) is of major concern in patients with complex therapeu...
Objective: This research was instigated to determine and assess the prevalence, severity, type, and ...
Objective: To determine the prevalence, clinical significance and the associated risk factors of pot...
Introduction: Drug-drug interactions are an important clinical problem in pharmacotherapy. This stud...
Potential Drug-Drug Interactions (pDDIs) possess a great risk in altering the therapeutic outcome in...
Background and Objectives: Patients with schizophrenia are often exposed to polypharmacotherapy, whi...
OBJECTIVE: The objective of this study was to identify Drug-Drug Interaction among the inpatient adm...
Potential drug-drug interactions (pDDIs) are a serious and frequent health issue, leading to often p...
Background: Drug interactions are estimated to occur between 3% and 5% in patients to whom few drugs...
Purpose: To identify the prevalence of potential drug-drug interactions (pDDIs) in a psychiatric war...
Purpose: To identify the prevalence of potential drug-drug interactions (pDDIs) in a psychiatric war...
Purpose: To identify and report the prevalence of potential drug-drug interactions (pDDIs) in a neur...
Purpose: To identify the frequency, levels and predictors of potential drug-drug interactions (pDDIs...
Purpose: To identify the frequency, levels and predictors of potential drug-drug interactions (pDDIs...
Background: Drug-drug interactions (DDIs) contribute majorly to hospital admissions, treatment failu...
Aim and objective: Drug-drug interaction (DDI) is of major concern in patients with complex therapeu...
Objective: This research was instigated to determine and assess the prevalence, severity, type, and ...
Objective: To determine the prevalence, clinical significance and the associated risk factors of pot...
Introduction: Drug-drug interactions are an important clinical problem in pharmacotherapy. This stud...
Potential Drug-Drug Interactions (pDDIs) possess a great risk in altering the therapeutic outcome in...
Background and Objectives: Patients with schizophrenia are often exposed to polypharmacotherapy, whi...
OBJECTIVE: The objective of this study was to identify Drug-Drug Interaction among the inpatient adm...
Potential drug-drug interactions (pDDIs) are a serious and frequent health issue, leading to often p...
Background: Drug interactions are estimated to occur between 3% and 5% in patients to whom few drugs...